Business
AstraZeneca COVID-19 vaccine trial volunteer ‘had neurological symptoms’ – Sydney Morning Herald
A woman in the trial in the UK had symptoms consistent with a rare but serious spinal inflammatory disorder, according to a report.
AstraZeneca said a woman in the United Kingdom had symptoms consistent with a rare but serious spinal inflammatory disorder, which led to the British drugmaker’s decision to stop its clinical study of the new coronavirus vaccine, Stat News has reported.
The participant was recovering and will likely be discharged from the hospital within a day, according to Stat News, which said on Wednesday the new disclosures by Astra Chief Executive Pascal Soriot were shared by three of the investors partici…
-
Noosa News22 hours agoEnsure voices are heard – Proctor
-
Business23 hours agoASX ETFs to target amidst an ageing population
-
Noosa News17 hours agoMajor crash on Gateway Motorway snarls morning commute
-
Noosa News22 hours agoEric Bana Is Back in Murder-Mystery Mode (and in Scenic Surroundings) in the Trailer for New Netflix Series ‘Untamed’